Vaccination with the recombinant major outer membrane protein elicits long-term protection in mice against vaginal shedding and infertility following a Chlamydia muridarum genital challenge

Seventy Years of Chlamydia Vaccine Research – Limitations of the Past and Directions for the Future

(2019) Samuel Phillips et al.   Frontiers in Microbiology

Characterization of the horizontal and vertical sexual transmission of Chlamydia genital infections in a new mouse model

(2019) Sukumar Pal et al.   INFECTION AND IMMUNITY

Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections

(2019) Cynthia Calzas et al.   Frontiers in Immunology

National Institute of Allergy and Infectious Diseases workshop report: “Chlamydia vaccines: The way forward”

(2017) Guangming Zhong et al.   VACCINE

A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells

(2015) G. Stary et al.   SCIENCE

Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting

(2015) Lori Newman et al.   PLoS One

Peyer's Patches as the Inductive Site for IgA Responses

(2014) J. Mestecky et al.   JOURNAL OF IMMUNOLOGY

Increased Immunoaccessibility of MOMP Epitopes in a Vaccine Formulated with Amphipols May Account for the Very Robust Protection Elicited against a Vaginal Challenge with Chlamydia muridarum

(2014) D. F. Tifrea et al.   JOURNAL OF IMMUNOLOGY

Towards a safe and effective chlamydial vaccine: Lessons from the eye

(2014) David C.W. Mabey et al.   VACCINE

Chlamydia trachomatis control requires a vaccine

(2013) Robert C. Brunham et al.   VACCINE

Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine

(2011) Jennifer R. Carmichael et al.   VACCINE

CD4+ T Cells and Antibody Are Required for Optimal Major Outer Membrane Protein Vaccine-Induced Immunity to Chlamydia muridarum Genital Infection

(2010) C. M. Farris et al.   INFECTION AND IMMUNITY

Vaccination againstChlamydiaGenital Infection Utilizing the MurineC. muridarumModel

(2010) Christina M. Farris et al.   INFECTION AND IMMUNITY

Risk of Sequelae afterChlamydia trachomatisGenital Infection in Women

(2010) Catherine L. Haggerty et al.   JOURNAL OF INFECTIOUS DISEASES

Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization

(2010) Pooja Ralli-Jain et al.   VACCINE

ORIGINAL ARTICLE: Two Different Homing Pathways Involving Integrin β7 and E-selectin Significantly Influence Trafficking of CD4 Cells to the Genital Tract Following Chlamydia muridarum Infection

(2009) Kathleen A. Kelly et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection

(2009) Jiri Mestecky et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein

(2009) Guifeng Sun et al.   VACCINE

Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes

(2008) Indresh Srivastava et al.   VACCINE

HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination

(2008) Hans Hsienhong Lin et al.   VACCINE

Colonic antigen administration induces significantly higher humoral levels of colonic and vaginal IgA, and serum IgG compared to oral administration

(2007) Emma L. McConnell et al.   VACCINE